Results 41 to 50 of about 7,404 (210)

Relationship satisfaction predicts sexual activity following risk-reducing salpingo-oophorectomy [PDF]

Journal of Psychosomatic Obstetrics & Gynecology, 2014
Changes in sexual function are a common outcome following risk-reducing salpingo-oophorectomy (RRSO), a prophylactic surgery for women at high risk of ovarian and other gynecologic cancers. Despite the known importance of sexuality in patients' quality of life and satisfaction with surgery, little is known about what predicts sexual activity following ...
Tierney, Lorenz, Bonnie, McGregor, Elizabeth, Swisher   +2 more
openaire   +2 more sources

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History-Based Testing [PDF]

, 2014
BACKGROUND: Population-based testing for BRCA1/2 mutations detects the high proportion of carriers not identified by cancer family history (FH)-based testing.
Abdel-Rahman, Ajith Kumar, Alistair McGuire, Anderson, Anderson, Andronis, Armstrong, Bahar, Balmana, Bates, Blamey, BNF, Bolton, Bordeleau, Boyd, Bradbury, Brandberg, Brandberg, Briggs, Chaliki, Chappuis, Chen, Chris Jacobs, Comen, Contant, Cortesi, CRUK, CRUK, Curtis, Curtis, Cuzick, Cyril Chapman, de Sanjose, Dedes, Department of Health PbR Team, Drummond, Evans, Evans, Finch, Finch, Friebel, Gennari, Graham, Gribbin, Griebsch, Hartge, Havrilesky, Heijnsdijk, Hirsh-Yechezkel, Hopper, Huw Dorkins, Ian Jacobs, Ian Tomlinson, Isern, Jacobs, Jane Wardle, Kadouri, Kelly Loggenberg, King, Kozlow, Kwon, Leach, Levy-Lahad, Lipton, Lokkegaard, Lucy Side, Lyratzopoulos, MacLennan, Madalinska, Madalinska, Manchanda, Manchanda, Manchanda, Maria Raikou, Matthew Burnell, Metcalfe, Metcalfe, Michelsen, Moller, NAO, Nelson, NICE, NICE, NICE, NICE, NICE, NICE, NICE, NICE, NICE. Clinical Guideline (CG81), Nyala Balogun, Office of National Statistics, Office of National Statistics, ONS, ONS, ONS, Peasgood, Peto, Petrou, Phillips, Press, Rakshit Desai, Ranjit Manchanda, Rebbeck, Rebbeck, Rebbeck, Rennert, Roa, Robertson, Robson, Robson, Rohan Taylor, Rosa Legood, Rubinstein, Saskia Sanderson, SEER, Shendure, Sigal, Skytte, Sturdee, Sue Gessler, Swart, Tambor, Tung, Usha Menon, Uziel Beller, Waldron, Walters, Wapnir, Wasteson, Yancik, Yang, Yvonne Wallis   +132 more
core   +4 more sources

Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience

Hereditary Cancer in Clinical Practice, 2023
Background In Japan, genetic testing, surveillance, and risk-reducing surgery for hereditary breast and ovarian cancer (HBOC) syndrome have been covered by the Japanese national insurance system since April 2020.
Aya Tanaka, Megumi Matsumoto, Mami Takao, Shoko Miura, Yuri Hasegawa, Ryota Otsubo, Hiroko Hayashi, Ichiro Isomoto, Kiyonori Miura, Takeshi Nagayasu   +9 more
doaj   +1 more source

Primary Peritoneal Cancer Two Decades after a Bilateral Salpingo-Oophorectomy

Case Reports in Obstetrics and Gynecology, 2019
Bilateral salpingo-oophorectomy (BSO) is increasingly employed as a risk-reducing strategy for epithelial ovarian cancer (EOC). We report the third case of a patient developing primary peritoneal cancer two decades after a bilateral salpingo-oophorectomy.
Melinda Rodowa, Amir H. Salehi, Jacob McGee   +2 more
doaj   +1 more source

Use of hormone replacement therapy after risk‐reducing salpingo‐oophorectomy [PDF]

Acta Obstetricia et Gynecologica Scandinavica, 2017
AbstractIntroductionAfter premenopausal risk‐reducing salpingo‐oophorectomy (RRSO) to prevent ovarian cancer, the non‐cancer‐related morbidity and mortality may be increased if sex hormones are not replaced. Several guidelines recommend systemic hormone replacement therapy (HRT) to these women until the expected age of menopause.
Nora Johansen, Astrid H. Liavaag, Ole‐Erik Iversen, Anne Dørum, Tonje Braaten, Trond M. Michelsen   +5 more
openaire   +2 more sources

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

Breast Cancer Research, 2020
Background The effect of risk-reducing salpingo-oophorectomy (RRSO) on breast cancer risk for BRCA1 and BRCA2 mutation carriers is uncertain. Retrospective analyses have suggested a protective effect but may be substantially biased.
Nasim Mavaddat, Antonis C. Antoniou, Thea M. Mooij, Maartje J. Hooning, Bernadette A. Heemskerk-Gerritsen, GENEPSO, Catherine Noguès, Marion Gauthier-Villars, Olivier Caron, Paul Gesta, Pascal Pujol, Alain Lortholary, EMBRACE, Daniel Barrowdale, Debra Frost, D. Gareth Evans, Louise Izatt, Julian Adlard, Ros Eeles, Carole Brewer, Marc Tischkowitz, Alex Henderson, Jackie Cook, Diana Eccles, HEBON, Klaartje van Engelen, Marian J. E. Mourits, Margreet G. E. M. Ausems, Linetta B. Koppert, John L. Hopper, Esther M. John, Wendy K. Chung, Irene L. Andrulis, Mary B. Daly, Saundra S. Buys, kConFab Investigators, Javier Benitez, Trinidad Caldes, Anna Jakubowska, Jacques Simard, Christian F. Singer, Yen Tan, Edith Olah, Marie Navratilova, Lenka Foretova, Anne-Marie Gerdes, Marie-José Roos-Blom, Flora E. Van Leeuwen, Brita Arver, Håkan Olsson, Rita K. Schmutzler, Christoph Engel, Karin Kast, Kelly-Anne Phillips, Mary Beth Terry, Roger L. Milne, David E. Goldgar, Matti A. Rookus, Nadine Andrieu, Douglas F. Easton, on behalf of IBCCS, kConFab, BCFR   +62 more
doaj   +1 more source

Hereditary Women’s Cancer: Management and Risk-Reducing Surgery

Medicina, 2023
Hereditary women’s syndromes due to inherited mutations result in an elevated risk of developing gynecological cancers over the lifetime of affected carriers.
Carmine Conte, Silvia Pelligra, Giuseppe Sarpietro, Giuseppe Dario Montana, Luigi Della Corte, Giuseppe Bifulco, Canio Martinelli, Alfredo Ercoli, Marco Palumbo, Stefano Cianci   +9 more
doaj   +1 more source

Understanding the Needs of Women Considering Risk-Reducing Salpingo-oophorectomy [PDF]

Cancer Nursing, 2013
Because of the significantly increased lifetime risk of ovarian cancer associated with inheritance of a germline mutation in the BRCA1/2 genes, women with a deleterious mutation are recommended to undergo risk-reducing salpingo-oophorectomy at age 35 years or once child-bearing is complete.
Carol, Cherry, Mary, Ropka, Jennifer, Lyle, Laura, Napolitano, Mary B, Daly   +4 more
openaire   +2 more sources

Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis [PDF]

, 2016
BACKGROUND: Risk-reducing salpingo-oophorectomy (RRSO) is the most effective intervention to prevent ovarian cancer (OC). It is only available to high-risk women with >10% lifetime OC risk.
Antoniou, AC, Gordeev, VS, Legood, R, Manchanda, R, Menon, U   +4 more
core   +1 more source

What Have We Learned from Risk-Reducing Salpingo-oophorectomy? [PDF]

JNCI Journal of the National Cancer Institute, 2009
In this issue of the Journal, Rebbeck et al. (1) have provided us with a meticulously executed, up-to-date meta-analysis that quantifies the reductions in the risks of breast and ovarian/fallopian tube cancer that follow risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 and BRCA2 (BRCA1/2) mutation carriers.
M. H. Greene, P. L. Mai
openaire   +1 more source